CALCIUM ACETATE

CALCIUM ACETATE was reported 5433 times

CALCIUM ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTURED SKULL DEPRESSED 4 0.2353
1 BROWN TUMOUR 4 0.0800
2 DIALYSIS HYPOTENSION 7 0.0707
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 71 0.0669
4 ORBITAL APEX SYNDROME 5 0.0602
5 ARTERIOVENOUS SHUNT OPERATION 3 0.0588
6 NEPHROGENIC ANAEMIA 213 0.0459
7 HYPERPARATHYROIDISM SECONDARY 112 0.0447
8 CALCIFICATION METASTATIC 4 0.0444
9 HAEMODIALYSIS COMPLICATION 7 0.0412
10 ARTERIOVENOUS FISTULA OCCLUSION 7 0.0400
11 RESPIRATORY TRACT INFECTION BACTERIAL 17 0.0341
12 SKIN FIBROSIS 14 0.0289
13 MILK-ALKALI SYNDROME 14 0.0268
14 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 5 0.0267
15 CALCIPHYLAXIS 47 0.0256
16 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 5 0.0253
17 PULMONARY CALCIFICATION 10 0.0242
18 END STAGE RENAL DISEASE 437 0.0239
19 ARTERIOVENOUS FISTULA THROMBOSIS 8 0.0231
20 RENAL HYPERTENSION 7 0.0225
21 ARTERIOVENOUS FISTULA SITE INFECTION 3 0.0222
22 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 5 0.0199
23 CAVERNOUS SINUS THROMBOSIS 5 0.0197
24 PSEUDOPORPHYRIA 6 0.0175
25 JOINT CONTRACTURE 17 0.0158
26 REBOUND ACID HYPERSECRETION 45 0.0149
27 ARTERIOVENOUS FISTULA OPERATION 4 0.0148
28 NEPHROGENIC SYSTEMIC FIBROSIS 43 0.0142
29 DIALYSIS RELATED COMPLICATION 5 0.0141
30 HYPERPHOSPHATAEMIA 29 0.0135
31 CHOREOATHETOSIS 9 0.0133
32 BLOOD PHOSPHORUS INCREASED 34 0.0124
33 SHUNT OCCLUSION 6 0.0118
34 TRANSFERRIN SATURATION DECREASED 5 0.0117
35 TRANSFERRIN SATURATION INCREASED 4 0.0116
36 ACUTE PHASE REACTION 4 0.0105
37 ARTERIOVENOUS FISTULA 5 0.0102
38 ALANINE AMINOTRANSFERASE DECREASED 7 0.0097
39 SKIN INDURATION 20 0.0096
40 AORTIC VALVE SCLEROSIS 7 0.0095
41 EXTREMITY CONTRACTURE 6 0.0094
42 MITRAL VALVE CALCIFICATION 6 0.0093
43 HAEMORRHAGIC OVARIAN CYST 5 0.0087
44 BLOOD PHOSPHORUS ABNORMAL 4 0.0085
45 ANISOCYTOSIS 5 0.0076
46 ENTEROCOCCAL SEPSIS 6 0.0074
47 RESPIRATORY TRACT INFECTION VIRAL 17 0.0073
48 URGE INCONTINENCE 6 0.0069
49 SKIN HYPERTROPHY 19 0.0068
50 ARTERIOVENOUS FISTULA SITE COMPLICATION 4 0.0067
51 LOWER EXTREMITY MASS 4 0.0065
52 APLASIA PURE RED CELL 22 0.0064
53 CHRONIC KIDNEY DISEASE 464 0.0061
54 PERITONEAL DIALYSIS 5 0.0060
55 FUNGAL PERITONITIS 9 0.0059
56 CONGENITAL CYSTIC KIDNEY DISEASE 5 0.0059
57 HYPERPARATHYROIDISM 12 0.0058
58 DELAYED GRAFT FUNCTION 4 0.0056
59 BLOOD PARATHYROID HORMONE INCREASED 16 0.0055
60 BLOOD CALCIUM ABNORMAL 9 0.0054
61 BASOPHIL COUNT INCREASED 4 0.0053
62 RECALLED PRODUCT 9 0.0052
63 FIBROSIS 16 0.0052
64 HYPERTENSIVE EMERGENCY 6 0.0051
65 AZOTAEMIA 20 0.0050
66 SYSTEMIC INFECTION 8 0.0048
67 DIALYSIS 68 0.0048
68 PERITONITIS BACTERIAL 48 0.0048
69 BLOOD PARATHYROID HORMONE ABNORMAL 3 0.0047
70 RENAL FAILURE CHRONIC 36 0.0047
71 HYPERCALCAEMIA 56 0.0045
72 KLEBSIELLA SEPSIS 5 0.0044
73 RENAL TUBULAR NECROSIS 43 0.0044
74 SCROTAL SWELLING 4 0.0043
75 GLOMERULONEPHRITIS MEMBRANOUS 5 0.0043
76 HAEMODIALYSIS 35 0.0042
77 SPLENIC INFARCTION 7 0.0040
78 GASTROINTESTINAL WALL THICKENING 6 0.0040
79 AORTIC ARTERIOSCLEROSIS 10 0.0039
80 SKIN TIGHTNESS 18 0.0038
81 RENAL FAILURE 484 0.0036
82 HYPERVOLAEMIA 18 0.0036
83 RENAL TRANSPLANT 13 0.0036
84 NEPHROPATHY 33 0.0035
85 RENAL INJURY 104 0.0035
86 HYPOCALCAEMIA 65 0.0034
87 PARAPARESIS 6 0.0034
88 ANAEMIA OF CHRONIC DISEASE 3 0.0033
89 ESSENTIAL HYPERTENSION 6 0.0033
90 OTITIS EXTERNA 4 0.0033
91 ECONOMIC PROBLEM 47 0.0031
92 BILIRUBIN CONJUGATED INCREASED 7 0.0030
93 CATHETER RELATED INFECTION 3 0.0030
94 THROMBOCYTOPENIC PURPURA 4 0.0029
95 SUBDURAL HAEMORRHAGE 8 0.0029
96 QUADRIPLEGIA 6 0.0029
97 PERITONEAL CLOUDY EFFLUENT 4 0.0029
98 TUBULOINTERSTITIAL NEPHRITIS 53 0.0028
99 PRODUCT MONITORING ERROR 4 0.0028
100 BLOOD PARATHYROID HORMONE DECREASED 4 0.0027
101 CALCINOSIS 6 0.0027
102 ANGIOPLASTY 4 0.0027
103 FLUID OVERLOAD 39 0.0027
104 HYPERTENSIVE HEART DISEASE 5 0.0027
105 BLOOD LOSS ANAEMIA 6 0.0026
106 BLOOD BICARBONATE DECREASED 5 0.0026
107 BLOOD CALCIUM INCREASED 23 0.0026
108 CYTOMEGALOVIRUS COLITIS 6 0.0026
109 CARBON DIOXIDE DECREASED 3 0.0026
110 ANHEDONIA 65 0.0025
111 ULTRAFILTRATION FAILURE 5 0.0025
112 ACUTE KIDNEY INJURY 378 0.0025
113 SERUM FERRITIN INCREASED 13 0.0025
114 VASCULAR OCCLUSION 5 0.0024
115 THORACIC VERTEBRAL FRACTURE 7 0.0024
116 SUDDEN CARDIAC DEATH 8 0.0023
117 HYPERKALAEMIA 82 0.0023
118 NORMOCHROMIC NORMOCYTIC ANAEMIA 7 0.0023
119 AMYLOIDOSIS 4 0.0023
120 PERITONITIS 48 0.0023
121 BLOOD ALBUMIN DECREASED 18 0.0023
122 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
123 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
124 ORTHOPNOEA 7 0.0022
125 BEZOAR 3 0.0022
126 BLOOD CALCIUM DECREASED 24 0.0021
127 BLOOD POTASSIUM INCREASED 34 0.0021
128 OCCULT BLOOD POSITIVE 4 0.0020
129 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
130 QUALITY OF LIFE DECREASED 27 0.0020
131 METABOLIC ENCEPHALOPATHY 6 0.0020
132 CATHETER SITE HAEMORRHAGE 5 0.0020
133 EXCORIATION 5 0.0020
134 ARTERIOSCLEROSIS 18 0.0019
135 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
136 OCULAR ICTERUS 8 0.0018
137 PROTHROMBIN TIME PROLONGED 11 0.0018
138 DIABETIC NEPHROPATHY 4 0.0018
139 CLOSTRIDIUM TEST POSITIVE 4 0.0018
140 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
141 PSEUDOMEMBRANOUS COLITIS 4 0.0018
142 GASTRITIS EROSIVE 8 0.0017
143 TUMOUR LYSIS SYNDROME 15 0.0017
144 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
145 DECREASED ACTIVITY 18 0.0017
146 DIABETIC FOOT 5 0.0016
147 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
148 STAPHYLOCOCCAL SEPSIS 8 0.0016
149 NECROSIS 9 0.0016
150 TACHYARRHYTHMIA 4 0.0016
151 DYSPHEMIA 7 0.0016
152 CATHETER SITE INFECTION 6 0.0016
153 AMMONIA INCREASED 8 0.0016
154 MEAN CELL VOLUME INCREASED 4 0.0016
155 THROMBOSIS IN DEVICE 5 0.0015
156 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
157 GANGRENE 9 0.0015
158 BLOOD UREA INCREASED 25 0.0015
159 PULSE ABSENT 7 0.0015
160 PERIPHERAL ISCHAEMIA 6 0.0015
161 HYPOVOLAEMIC SHOCK 7 0.0015
162 WOUND COMPLICATION 5 0.0015
163 PRE-EXISTING CONDITION IMPROVED 9 0.0014
164 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
165 AORTIC STENOSIS 5 0.0014
166 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
167 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
168 FLUSHING 144 0.0014
169 BUNDLE BRANCH BLOCK LEFT 6 0.0014
170 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
171 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
172 ATRIAL FLUTTER 11 0.0014
173 TOE AMPUTATION 7 0.0014
174 TRANSPLANT REJECTION 11 0.0014
175 PERITONEAL DIALYSIS COMPLICATION 10 0.0014
176 HYPOPHOSPHATAEMIA 10 0.0014
177 SKIN NECROSIS 7 0.0013
178 RHINITIS ALLERGIC 6 0.0013
179 ATELECTASIS 13 0.0013
180 MENTAL STATUS CHANGES 37 0.0013
181 CENTRAL VENOUS CATHETERISATION 4 0.0013
182 ABNORMAL LOSS OF WEIGHT 9 0.0013
183 NEPHROTIC SYNDROME 9 0.0013
184 LUMBAR VERTEBRAL FRACTURE 6 0.0013
185 STRESS FRACTURE 7 0.0013
186 DIASTOLIC DYSFUNCTION 4 0.0013
187 DEFORMITY 12 0.0013
188 SKIN HYPERPIGMENTATION 11 0.0013
189 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
190 HAND FRACTURE 9 0.0013
191 JOINT RANGE OF MOTION DECREASED 17 0.0013
192 KIDNEY TRANSPLANT REJECTION 6 0.0012
193 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
194 LOOSE TOOTH 4 0.0012
195 ARTHRITIS BACTERIAL 5 0.0012
196 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
197 DIABETIC NEUROPATHY 6 0.0012
198 ELECTROLYTE IMBALANCE 14 0.0012
199 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
200 PULMONARY OEDEMA 53 0.0012
201 BACTERAEMIA 14 0.0012
202 DIABETIC RETINOPATHY 4 0.0012
203 ABSCESS LIMB 5 0.0012
204 PURULENT DISCHARGE 5 0.0012
205 ECCHYMOSIS 8 0.0012
206 PERIPHERAL VASCULAR DISORDER 6 0.0012
207 BLOOD CHLORIDE DECREASED 3 0.0012
208 LEFT VENTRICULAR FAILURE 4 0.0012
209 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
210 PARTIAL SEIZURES 6 0.0011
211 CAROTID ARTERY STENOSIS 4 0.0011
212 HIP SURGERY 6 0.0011
213 FAECALOMA 6 0.0011
214 HYPERLIPIDAEMIA 13 0.0011
215 AMYLASE INCREASED 4 0.0011
216 FISTULA 12 0.0011
217 PROTEIN TOTAL DECREASED 4 0.0011
218 HAEMOGLOBIN DECREASED 109 0.0011
219 MITRAL VALVE INCOMPETENCE 12 0.0011
220 VENTRICULAR EXTRASYSTOLES 11 0.0011
221 BLOOD CREATININE INCREASED 69 0.0011
222 SCAR 18 0.0011
223 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
224 SENSATION OF HEAVINESS 4 0.0010
225 SPINAL CORD COMPRESSION 4 0.0010
226 AFFECTIVE DISORDER 8 0.0010
227 RENAL CYST 8 0.0010
228 TRICUSPID VALVE INCOMPETENCE 8 0.0010
229 LOW BIRTH WEIGHT BABY 8 0.0010
230 LOW TURNOVER OSTEOPATHY 4 0.0010
231 WRIST FRACTURE 12 0.0010
232 ERYSIPELAS 5 0.0010
233 KLEBSIELLA INFECTION 5 0.0010
234 GALLBLADDER OPERATION 4 0.0010
235 TOXIC ENCEPHALOPATHY 5 0.0010
236 CARDIAC ARREST 81 0.0010
237 IRON DEFICIENCY ANAEMIA 9 0.0010
238 TREATMENT NONCOMPLIANCE 53 0.0010
239 SEPSIS 108 0.0010
240 RENAL FAILURE ACUTE 41 0.0010
241 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
242 MALABSORPTION 5 0.0010
243 BLOOD SODIUM DECREASED 18 0.0010
244 ASCITES 28 0.0010
245 SLEEP APNOEA SYNDROME 18 0.0009
246 LEUKOCYTOSIS 17 0.0009
247 POOR PERIPHERAL CIRCULATION 4 0.0009
248 CARDIAC FAILURE CHRONIC 4 0.0009
249 BLOOD MAGNESIUM DECREASED 8 0.0009
250 TROPONIN INCREASED 7 0.0009
251 URINE OUTPUT DECREASED 8 0.0009
252 ONYCHOMYCOSIS 4 0.0009
253 DEVICE RELATED INFECTION 14 0.0009
254 HAEMOLYSIS 7 0.0009
255 HYPERKERATOSIS 5 0.0009
256 LUNG INFILTRATION 8 0.0009
257 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
258 BLOOD POTASSIUM DECREASED 27 0.0009
259 CARDIOMEGALY 11 0.0009
260 POSTOPERATIVE WOUND INFECTION 6 0.0009
261 COLECTOMY 5 0.0009
262 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
263 ISCHAEMIA 4 0.0009
264 SKIN ATROPHY 5 0.0009
265 LARGE INTESTINE PERFORATION 6 0.0009
266 CORONARY ARTERY DISEASE 26 0.0009
267 YELLOW SKIN 4 0.0009
268 SINUS TACHYCARDIA 12 0.0008
269 RESPIRATORY TRACT INFECTION 22 0.0008
270 FOOT FRACTURE 16 0.0008
271 RENAL DISORDER 39 0.0008
272 BONE LESION 3 0.0008
273 ACUTE RESPIRATORY FAILURE 16 0.0008
274 RASH VESICULAR 4 0.0008
275 FLUID RETENTION 42 0.0008
276 DIZZINESS POSTURAL 8 0.0008
277 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
278 CARDIAC FAILURE CONGESTIVE 66 0.0008
279 ENCEPHALOPATHY 20 0.0008
280 ANAEMIA 155 0.0008
281 SKIN ULCER 21 0.0008
282 BREATH SOUNDS ABNORMAL 4 0.0008
283 HOSPICE CARE 8 0.0008
284 MALNUTRITION 9 0.0008
285 SEPTIC SHOCK 35 0.0008
286 RESPIRATORY DISTRESS 22 0.0008
287 SPINAL OSTEOARTHRITIS 7 0.0008
288 CARDIO-RESPIRATORY ARREST 33 0.0008
289 PLEURAL EFFUSION 48 0.0008
290 RENAL IMPAIRMENT 66 0.0008
291 SUBARACHNOID HAEMORRHAGE 8 0.0008
292 HYPOGLYCAEMIA 38 0.0008
293 COAGULOPATHY 13 0.0008
294 ENDOCARDITIS 4 0.0008
295 PRODUCT COLOUR ISSUE 4 0.0008
296 UNRESPONSIVE TO STIMULI 20 0.0008
297 OSTEOMYELITIS 14 0.0008
298 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
299 MELAENA 17 0.0008
300 HAEMATOMA 20 0.0008
301 FAILURE TO THRIVE 4 0.0008
302 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
303 PETECHIAE 8 0.0008
304 TORSADE DE POINTES 6 0.0008
305 FULL BLOOD COUNT ABNORMAL 8 0.0008
306 PANCREATITIS ACUTE 17 0.0008
307 MYOCLONUS 9 0.0008
308 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
309 GASTROENTERITIS 11 0.0008
310 OVERWEIGHT 4 0.0007
311 PRODUCT SIZE ISSUE 4 0.0007
312 BRONCHIECTASIS 5 0.0007
313 NOCTURIA 9 0.0007
314 HYPOXIA 26 0.0007
315 NO THERAPEUTIC RESPONSE 9 0.0007
316 SHOCK HAEMORRHAGIC 6 0.0007
317 HYDROCEPHALUS 4 0.0007
318 WOUND INFECTION 8 0.0007
319 HYPOAESTHESIA ORAL 11 0.0007
320 ANAPHYLACTOID REACTION 3 0.0007
321 JOINT EFFUSION 5 0.0007
322 CYST 9 0.0007
323 ACUTE CORONARY SYNDROME 6 0.0007
324 VENTRICULAR FIBRILLATION 8 0.0007
325 STREPTOCOCCAL INFECTION 4 0.0007
326 VITAMIN D DEFICIENCY 7 0.0007
327 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
328 ACUTE PULMONARY OEDEMA 4 0.0007
329 SKIN PLAQUE 6 0.0007
330 EMOTIONAL DISTRESS 86 0.0007
331 HAEMATOCRIT DECREASED 14 0.0007
332 AORTIC VALVE INCOMPETENCE 3 0.0007
333 GENERALISED ERYTHEMA 4 0.0007
334 MYOCARDIAL ISCHAEMIA 8 0.0007
335 NEUROLOGICAL SYMPTOM 4 0.0007
336 SUBDURAL HAEMATOMA 10 0.0007
337 PANCYTOPENIA 39 0.0007
338 CARDIOGENIC SHOCK 10 0.0007
339 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
340 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
341 MAJOR DEPRESSION 5 0.0007
342 HYPOVOLAEMIA 4 0.0007
343 HYPOTENSION 137 0.0007
344 SPLENOMEGALY 8 0.0007
345 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
346 OSTEOPOROSIS 28 0.0007
347 LEUKOPENIA 34 0.0007
348 CARDIOMYOPATHY 10 0.0007
349 CHOLECYSTITIS 8 0.0007
350 RASH PAPULAR 15 0.0007
351 WEIGHT FLUCTUATION 7 0.0007
352 HYDRONEPHROSIS 5 0.0007
353 HYPOPHAGIA 17 0.0007
354 HEPATIC FAILURE 20 0.0007
355 PEMPHIGOID 5 0.0007
356 TACHYPNOEA 9 0.0007
357 IMPAIRED GASTRIC EMPTYING 9 0.0007
358 RESTLESS LEGS SYNDROME 12 0.0007
359 OSTEOPENIA 10 0.0007
360 GASTROINTESTINAL HAEMORRHAGE 55 0.0007
361 INGUINAL HERNIA 4 0.0007
362 BODY HEIGHT DECREASED 7 0.0007
363 ACIDOSIS 5 0.0007
364 INSURANCE ISSUE 10 0.0007
365 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
366 FEELING HOT 40 0.0007
367 PROCEDURAL COMPLICATION 5 0.0007
368 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
369 MUSCLE TWITCHING 15 0.0007
370 PERICARDIAL EFFUSION 15 0.0006
371 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 31 0.0006
372 ACUTE MYOCARDIAL INFARCTION 19 0.0006
373 LUNG INFECTION 10 0.0006
374 ABORTION INDUCED 6 0.0006
375 MULTI-ORGAN FAILURE 11 0.0006
376 INFUSION SITE SWELLING 4 0.0006
377 TOOTH FRACTURE 7 0.0006
378 OEDEMA PERIPHERAL 77 0.0006
379 ULCER 10 0.0006
380 BLOOD GLUCOSE DECREASED 30 0.0006
381 PULMONARY HYPERTENSION 13 0.0006
382 HAEMOGLOBIN ABNORMAL 4 0.0006
383 LOCALISED INFECTION 15 0.0006
384 RHINITIS 5 0.0006
385 PLATELET COUNT DECREASED 66 0.0006
386 CARDIAC FLUTTER 4 0.0006
387 RESPIRATORY FAILURE 45 0.0006
388 PLASMA CELL MYELOMA 24 0.0006
389 JOINT STIFFNESS 16 0.0006
390 SOMNAMBULISM 4 0.0006
391 THROMBOCYTOPENIA 68 0.0006
392 ESCHERICHIA INFECTION 5 0.0006
393 PULMONARY CONGESTION 8 0.0006
394 WALKING AID USER 4 0.0006
395 SPINAL COMPRESSION FRACTURE 5 0.0006
396 BLADDER DISORDER 6 0.0006
397 ABDOMINAL TENDERNESS 3 0.0006
398 BONE DISORDER 11 0.0006
399 ANEURYSM 3 0.0006
400 VASCULITIS 7 0.0006
401 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
402 CYSTITIS 19 0.0006
403 FULL BLOOD COUNT DECREASED 12 0.0006
404 EMPHYSEMA 6 0.0006
405 RED BLOOD CELL COUNT DECREASED 17 0.0006
406 METABOLIC ACIDOSIS 19 0.0006
407 COLITIS ISCHAEMIC 4 0.0006
408 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
409 ATAXIA 7 0.0006
410 DRUG TOXICITY 8 0.0006
411 VITAMIN D DECREASED 5 0.0006
412 MOBILITY DECREASED 42 0.0006
413 CROHN'S DISEASE 4 0.0006
414 RECTAL HAEMORRHAGE 25 0.0006
415 DROOLING 4 0.0006
416 MUSCLE STRAIN 5 0.0006
417 C-REACTIVE PROTEIN INCREASED 21 0.0006
418 OEDEMA 31 0.0006
419 DEFAECATION URGENCY 4 0.0006
420 NEUROTOXICITY 10 0.0006
421 HERNIA 11 0.0006
422 INCONTINENCE 6 0.0006
423 PURPURA 5 0.0006
424 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
425 GOUT 10 0.0006
426 BLOOD PRESSURE DECREASED 37 0.0006
427 BRUXISM 3 0.0006
428 ANAL INCONTINENCE 5 0.0006
429 PRURITUS GENERALISED 12 0.0006
430 FAECES DISCOLOURED 12 0.0006
431 HAEMATEMESIS 14 0.0006
432 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
433 OESOPHAGITIS 6 0.0005
434 ORAL DISORDER 4 0.0005
435 SKIN DISCOLOURATION 25 0.0005
436 INCREASED TENDENCY TO BRUISE 5 0.0005
437 ANOREXIA 7 0.0005
438 NERVE COMPRESSION 5 0.0005
439 HIATUS HERNIA 7 0.0005
440 WOUND 15 0.0005
441 MIDDLE INSOMNIA 10 0.0005
442 HYPONATRAEMIA 30 0.0005
443 CONSTIPATION 116 0.0005
444 HEMIPARESIS 9 0.0005
445 PNEUMONIA 171 0.0005
446 BLOOD COUNT ABNORMAL 8 0.0005
447 GASTRIC ULCER 10 0.0005
448 CHOLECYSTECTOMY 6 0.0005
449 HAEMODYNAMIC INSTABILITY 4 0.0005
450 MUSCULOSKELETAL DISCOMFORT 9 0.0005
451 LIPASE INCREASED 4 0.0005
452 BLOOD URIC ACID INCREASED 3 0.0005
453 DIARRHOEA 335 0.0005
454 IMPAIRED HEALING 17 0.0005
455 CELLULITIS 26 0.0005
456 STAPHYLOCOCCAL INFECTION 17 0.0005
457 APNOEA 4 0.0005
458 PELVIC FRACTURE 4 0.0005
459 THROMBOTIC MICROANGIOPATHY 5 0.0005
460 PULMONARY HAEMORRHAGE 4 0.0005
461 PERIPHERAL COLDNESS 7 0.0005
462 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
463 DIVERTICULITIS 14 0.0005
464 DYSPNOEA EXERTIONAL 19 0.0005
465 INABILITY TO AFFORD MEDICATION 5 0.0005
466 HYPOMAGNESAEMIA 7 0.0005
467 GINGIVAL PAIN 4 0.0005
468 ANXIETY 142 0.0005
469 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
470 SEASONAL ALLERGY 7 0.0005
471 ADRENAL INSUFFICIENCY 6 0.0005
472 DECUBITUS ULCER 4 0.0005
473 CYTOPENIA 6 0.0005
474 HICCUPS 4 0.0005
475 SPINAL OPERATION 6 0.0005
476 CARDIAC FAILURE 39 0.0005
477 VENTRICULAR TACHYCARDIA 8 0.0005
478 INJURY 34 0.0005
479 ILEUS 6 0.0005
480 HYPERBILIRUBINAEMIA 5 0.0005
481 TOOTH LOSS 10 0.0005
482 CARDIAC DISORDER 45 0.0005
483 VIRAL INFECTION 16 0.0005
484 OXYGEN SATURATION DECREASED 27 0.0005
485 TENDERNESS 5 0.0005
486 RHABDOMYOLYSIS 20 0.0005
487 LIMB INJURY 13 0.0005
488 INTESTINAL OBSTRUCTION 18 0.0005
489 HYPOKALAEMIA 22 0.0005
490 ASTHENIA 179 0.0005
491 FRACTURE 9 0.0005
492 PRODUCT DOSE OMISSION 31 0.0005
493 HALLUCINATION, VISUAL 10 0.0005
494 PROTEINURIA 9 0.0005
495 MUSCULOSKELETAL DISORDER 9 0.0005
496 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
497 RESPIRATORY ARREST 13 0.0005
498 HYPOTHYROIDISM 15 0.0005
499 HAEMATURIA 16 0.0005
500 PSEUDOMONAS INFECTION 4 0.0005
501 CARDIAC OPERATION 4 0.0005
502 ANURIA 4 0.0005
503 PULMONARY EMBOLISM 44 0.0005
504 EAR PAIN 9 0.0005
505 CARDIAC MURMUR 4 0.0005
506 HOSPITALISATION 71 0.0005
507 HAEMORRHOIDS 9 0.0005
508 ORTHOSTATIC HYPOTENSION 8 0.0005
509 HYPERTENSION 97 0.0005
510 NAIL DISORDER 4 0.0005
511 ASPIRATION 5 0.0005
512 INTENTIONAL DOSE OMISSION 13 0.0005
513 GRIP STRENGTH DECREASED 4 0.0005
514 NEURALGIA 11 0.0005
515 MUSCLE SPASMS 83 0.0005
516 GENERAL PHYSICAL HEALTH DETERIORATION 52 0.0004
517 CYTOKINE RELEASE SYNDROME 9 0.0004
518 SWOLLEN TONGUE 14 0.0004
519 PRURITUS 172 0.0004
520 BREAST MASS 3 0.0004
521 ORAL PAIN 10 0.0004
522 NEPHROPATHY TOXIC 5 0.0004
523 DYSSTASIA 13 0.0004
524 SICKLE CELL ANAEMIA WITH CRISIS 7 0.0004
525 ARRHYTHMIA 21 0.0004
526 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
527 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
528 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
529 PREMATURE DELIVERY 7 0.0004
530 ACUTE HEPATIC FAILURE 6 0.0004
531 HAEMATOCHEZIA 24 0.0004
532 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
533 BRADYCARDIA 23 0.0004
534 ATRIAL FIBRILLATION 42 0.0004
535 PERSONALITY CHANGE 4 0.0004
536 HAEMOPTYSIS 12 0.0004
537 APPENDICITIS 4 0.0004
538 HEART RATE DECREASED 15 0.0004
539 BONE PAIN 25 0.0004
540 FLANK PAIN 4 0.0004
541 CHEST PAIN 79 0.0004
542 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
543 PHOTOPHOBIA 8 0.0004
544 RASH PRURITIC 23 0.0004
545 ABDOMINAL DISCOMFORT 71 0.0004
546 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
547 SPINAL DISORDER 4 0.0004
548 CYTOMEGALOVIRUS INFECTION 7 0.0004
549 FALL 140 0.0004
550 MUCOSAL INFLAMMATION 11 0.0004
551 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
552 ANGINA PECTORIS 12 0.0004
553 DYSPNOEA 237 0.0004
554 HYPERSOMNIA 12 0.0004
555 GASTRITIS 11 0.0004
556 POST PROCEDURAL COMPLICATION 8 0.0004
557 BONE DENSITY DECREASED 13 0.0004
558 MYELODYSPLASTIC SYNDROME 6 0.0004
559 HYPERCHOLESTEROLAEMIA 4 0.0004
560 SINUS BRADYCARDIA 4 0.0004
561 ERUCTATION 8 0.0004
562 DYSTONIA 8 0.0004
563 THERAPEUTIC RESPONSE DECREASED 25 0.0004
564 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
565 PRESYNCOPE 10 0.0004
566 VITREOUS FLOATERS 4 0.0004
567 LIGAMENT SPRAIN 4 0.0004
568 HIP FRACTURE 13 0.0004
569 SKIN LESION 11 0.0004
570 HYPOTONIA 4 0.0004
571 PARAESTHESIA 63 0.0004
572 PNEUMONIA ASPIRATION 10 0.0004
573 DEPRESSION 91 0.0004
574 EOSINOPHILIA 7 0.0004
575 PREMATURE BABY 12 0.0004
576 DEHYDRATION 53 0.0004
577 NEUTROPENIA 54 0.0004
578 CHOLELITHIASIS 13 0.0004
579 ABDOMINAL PAIN 92 0.0004
580 CONTUSION 38 0.0004
581 DEMENTIA 11 0.0004
582 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
583 SURGERY 23 0.0004
584 HEPATIC CYTOLYSIS 5 0.0004
585 BRONCHITIS 29 0.0004
586 CEREBRAL HAEMORRHAGE 14 0.0004
587 PHARYNGEAL OEDEMA 6 0.0004
588 CONFUSIONAL STATE 63 0.0004
589 SKIN DISORDER 13 0.0004
590 WHEEZING 23 0.0004
591 EPISTAXIS 29 0.0004
592 SKELETAL INJURY 4 0.0004
593 SWELLING FACE 25 0.0004
594 URINARY TRACT INFECTION 65 0.0004
595 PRODUCT USE COMPLAINT 6 0.0004
596 SUDDEN DEATH 4 0.0004
597 OBESITY 6 0.0004
598 SCIATICA 6 0.0004
599 EATING DISORDER 8 0.0004
600 IMPAIRED WORK ABILITY 8 0.0004
601 DRUG INTERACTION 59 0.0004
602 HOT FLUSH 28 0.0004
603 VOMITING 174 0.0004
604 UNEVALUABLE EVENT 28 0.0004
605 MUSCULAR WEAKNESS 42 0.0004
606 CEREBRAL INFARCTION 9 0.0004
607 BACK INJURY 4 0.0004
608 ABNORMAL FAECES 3 0.0004
609 DYSPEPSIA 36 0.0004
610 LETHARGY 21 0.0004
611 PULMONARY FIBROSIS 7 0.0004
612 ABASIA 9 0.0004
613 HAEMORRHAGE 38 0.0004
614 INJECTION SITE NODULE 4 0.0004
615 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
616 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
617 HYPERTENSIVE CRISIS 4 0.0004
618 COORDINATION ABNORMAL 5 0.0004
619 INTESTINAL PERFORATION 4 0.0004
620 ERYTHEMA 73 0.0004
621 EYE INFECTION 4 0.0004
622 DIABETES MELLITUS 27 0.0004
623 HEART RATE IRREGULAR 8 0.0004
624 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
625 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
626 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
627 BACK PAIN 82 0.0004
628 CIRCULATORY COLLAPSE 6 0.0004
629 UPPER LIMB FRACTURE 7 0.0004
630 SYNCOPE 35 0.0003
631 SPINAL FRACTURE 7 0.0003
632 PARALYSIS 5 0.0003
633 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
634 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
635 GASTROINTESTINAL DISORDER 31 0.0003
636 DYSARTHRIA 13 0.0003
637 EYELID OEDEMA 4 0.0003
638 MUSCULOSKELETAL PAIN 18 0.0003
639 CEREBROVASCULAR ACCIDENT 58 0.0003
640 NIGHT SWEATS 11 0.0003
641 NAUSEA 270 0.0003
642 DECREASED APPETITE 79 0.0003
643 GAIT DISTURBANCE 65 0.0003
644 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
645 BLISTER 19 0.0003
646 FATIGUE 262 0.0003
647 ISCHAEMIC STROKE 6 0.0003
648 PRODUCT PRESCRIBING ERROR 8 0.0003
649 THIRST 6 0.0003
650 POLLAKIURIA 14 0.0003
651 PULMONARY MASS 5 0.0003
652 ABDOMINAL PAIN UPPER 69 0.0003
653 FLATULENCE 19 0.0003
654 SKIN BURNING SENSATION 24 0.0003
655 ACCIDENT 4 0.0003
656 MUSCLE RIGIDITY 4 0.0003
657 RESPIRATORY DISORDER 10 0.0003
658 HEART RATE INCREASED 33 0.0003
659 GASTROENTERITIS VIRAL 6 0.0003
660 CONVULSION 19 0.0003
661 TOOTHACHE 6 0.0003
662 APHASIA 10 0.0003
663 MUSCULOSKELETAL STIFFNESS 29 0.0003
664 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
665 OSTEOARTHRITIS 14 0.0003
666 HYPERGLYCAEMIA 12 0.0003
667 DISORIENTATION 13 0.0003
668 JOINT INJURY 7 0.0003
669 RESPIRATORY DEPRESSION 4 0.0003
670 ABNORMAL DREAMS 9 0.0003
671 LIVER INJURY 8 0.0003
672 ABDOMINAL DISTENSION 34 0.0003
673 POOR QUALITY SLEEP 7 0.0003
674 PROCEDURAL PAIN 9 0.0003
675 CONJUNCTIVITIS 6 0.0003
676 OSTEONECROSIS OF JAW 8 0.0003
677 GENERALISED OEDEMA 4 0.0003
678 MUSCULOSKELETAL CHEST PAIN 5 0.0003
679 DELUSION 5 0.0003
680 THERAPY INTERRUPTED 23 0.0003
681 EJECTION FRACTION DECREASED 5 0.0003
682 LOSS OF CONSCIOUSNESS 41 0.0003
683 POISONING 4 0.0003
684 CYANOSIS 5 0.0003
685 BRAIN OEDEMA 4 0.0003
686 ABDOMINAL PAIN LOWER 8 0.0003
687 MYOCARDIAL INFARCTION 55 0.0003
688 TRANSAMINASES INCREASED 7 0.0003
689 RASH MACULO-PAPULAR 7 0.0003
690 SOMNOLENCE 63 0.0003
691 DIZZINESS 156 0.0003
692 HEPATITIS 8 0.0003
693 DRUG PRESCRIBING ERROR 6 0.0003
694 PAIN IN EXTREMITY 92 0.0003
695 PYREXIA 108 0.0003
696 INFUSION SITE PAIN 4 0.0003
697 BLOOD GLUCOSE INCREASED 58 0.0003
698 PAIN 189 0.0003
699 CHILLS 36 0.0003
700 NODULE 4 0.0003
701 KIDNEY INFECTION 6 0.0003
702 NEPHROLITHIASIS 14 0.0003
703 LABORATORY TEST ABNORMAL 9 0.0003
704 BODY TEMPERATURE DECREASED 3 0.0003
705 METASTASES TO BONE 5 0.0003
706 MULTIPLE FRACTURES 5 0.0003
707 TOOTH INFECTION 4 0.0003
708 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
709 PHOTOSENSITIVITY REACTION 5 0.0003
710 HYPERHIDROSIS 39 0.0003
711 FEBRILE NEUTROPENIA 20 0.0003
712 TREMOR 50 0.0003
713 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
714 RESTLESSNESS 11 0.0003
715 LIP SWELLING 10 0.0003
716 MALAISE 131 0.0003
717 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
718 TOXICITY TO VARIOUS AGENTS 50 0.0003
719 TASTE DISORDER 6 0.0003
720 ANGER 10 0.0003
721 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
722 BLINDNESS 12 0.0003
723 NEUROPATHY PERIPHERAL 28 0.0003
724 BODY TEMPERATURE INCREASED 6 0.0003
725 PALLOR 8 0.0003
726 WEIGHT DECREASED 82 0.0003
727 MIGRAINE 28 0.0003
728 CHEST DISCOMFORT 30 0.0003
729 GINGIVAL BLEEDING 4 0.0003
730 COUGH 82 0.0003
731 HALLUCINATION 22 0.0003
732 INFECTION 42 0.0003
733 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
734 BALANCE DISORDER 25 0.0003
735 INSOMNIA 77 0.0003
736 DELIRIUM 10 0.0003
737 MEDICATION ERROR 16 0.0003
738 HUNGER 4 0.0003
739 ROAD TRAFFIC ACCIDENT 12 0.0003
740 LUNG DISORDER 14 0.0003
741 CARPAL TUNNEL SYNDROME 4 0.0003
742 DEATH 246 0.0003
743 DYSPHAGIA 27 0.0003
744 HEAD INJURY 9 0.0003
745 BLINDNESS UNILATERAL 4 0.0003
746 TARDIVE DYSKINESIA 8 0.0003
747 DRY MOUTH 23 0.0003
748 LYMPHOPENIA 4 0.0003
749 DYSGEUSIA 21 0.0003
750 LYMPHADENOPATHY 10 0.0003
751 PALPITATIONS 33 0.0003
752 BLOOD PRESSURE INCREASED 43 0.0003
753 HYPOAESTHESIA 42 0.0003
754 DRY EYE 14 0.0003
755 STOMATITIS 17 0.0003
756 IRRITABLE BOWEL SYNDROME 6 0.0003
757 BLOOD CHOLESTEROL INCREASED 13 0.0003
758 HERPES ZOSTER 16 0.0003
759 INJECTION SITE HAEMATOMA 4 0.0003
760 ARTHRALGIA 114 0.0003
761 OCULAR HYPERAEMIA 13 0.0003
762 PERIPHERAL SWELLING 42 0.0003
763 DYSURIA 10 0.0003
764 DYSKINESIA 11 0.0003
765 RASH GENERALISED 7 0.0003
766 SKIN HAEMORRHAGE 4 0.0003
767 TOOTH DISORDER 6 0.0003
768 URINARY RETENTION 9 0.0003
769 HEPATIC STEATOSIS 5 0.0003
770 COLON CANCER 4 0.0003
771 BACTERIAL INFECTION 5 0.0003
772 COVID-19 47 0.0003
773 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
774 BLOOD URINE PRESENT 5 0.0003
775 DRUG ADMINISTRATION ERROR 8 0.0003
776 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
777 DRUG DOSE OMISSION 43 0.0003
778 EMOTIONAL DISORDER 8 0.0003
779 BLOOD BILIRUBIN INCREASED 7 0.0003
780 NEOPLASM PROGRESSION 9 0.0003
781 MYALGIA 44 0.0003
782 AGITATION 19 0.0003
783 LIMB DISCOMFORT 8 0.0003
784 ANKLE FRACTURE 4 0.0003
785 BURNING SENSATION 18 0.0003
786 CHOKING 5 0.0003
787 SKIN FISSURES 5 0.0003
788 SINUSITIS 26 0.0003
789 ANAPHYLACTIC REACTION 14 0.0003
790 BLOOD IRON DECREASED 3 0.0003
791 HALLUCINATION, AUDITORY 4 0.0003
792 ABSCESS 4 0.0003
793 NECK PAIN 14 0.0003
794 THROMBOSIS 20 0.0002
795 JOINT SWELLING 30 0.0002
796 DRUG INTOLERANCE 24 0.0002
797 TACHYCARDIA 22 0.0002
798 MENTAL IMPAIRMENT 6 0.0002
799 BURSITIS 3 0.0002
800 PAIN IN JAW 7 0.0002
801 MUSCLE TIGHTNESS 4 0.0002
802 FEEDING DISORDER 5 0.0002
803 VERTIGO 15 0.0002
804 BONE MARROW FAILURE 5 0.0002
805 NEUTROPHIL COUNT DECREASED 10 0.0002
806 INFLUENZA LIKE ILLNESS 20 0.0002
807 INFLUENZA 27 0.0002
808 VISUAL IMPAIRMENT 30 0.0002
809 EYE SWELLING 9 0.0002
810 RASH 104 0.0002
811 MOUTH ULCERATION 5 0.0002
812 HEADACHE 148 0.0002
813 RETCHING 5 0.0002
814 NASOPHARYNGITIS 43 0.0002
815 DRY SKIN 31 0.0002
816 DIPLOPIA 6 0.0002
817 AMNESIA 15 0.0002
818 PRODUCTIVE COUGH 11 0.0002
819 DEAFNESS 6 0.0002
820 EPILEPSY 7 0.0002
821 RASH MACULAR 8 0.0002
822 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
823 SWELLING 21 0.0002
824 GALLBLADDER DISORDER 4 0.0002
825 FEAR 6 0.0002
826 PAIN OF SKIN 6 0.0002
827 PNEUMONITIS 6 0.0002
828 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
829 CATARACT 13 0.0002
830 SHOCK 5 0.0002
831 ARTHRITIS 17 0.0002
832 DEEP VEIN THROMBOSIS 14 0.0002
833 AGRANULOCYTOSIS 4 0.0002
834 THINKING ABNORMAL 4 0.0002
835 ALOPECIA 42 0.0002
836 SLEEP DISORDER 15 0.0002
837 VISION BLURRED 29 0.0002
838 FUNGAL INFECTION 7 0.0002
839 SPEECH DISORDER 11 0.0002
840 FEELING JITTERY 4 0.0002
841 BLOOD PRESSURE FLUCTUATION 5 0.0002
842 LIVER FUNCTION TEST ABNORMAL 6 0.0002
843 APATHY 3 0.0002
844 NASAL CONGESTION 12 0.0002
845 URINARY INCONTINENCE 6 0.0002
846 DISABILITY 4 0.0002
847 SINUS DISORDER 4 0.0002
848 SKIN EXFOLIATION 17 0.0002
849 WEIGHT INCREASED 45 0.0002
850 PRESCRIBED UNDERDOSE 4 0.0002
851 BONE LOSS 3 0.0002
852 HYPERSENSITIVITY 37 0.0002
853 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
854 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
855 CARDIOVASCULAR DISORDER 5 0.0002
856 INJECTION SITE RASH 6 0.0002
857 RIB FRACTURE 4 0.0002
858 ILLNESS 20 0.0002
859 FEMUR FRACTURE 6 0.0002
860 BRAIN FOG 3 0.0002
861 SEDATION 5 0.0002
862 MEMORY IMPAIRMENT 26 0.0002
863 PANCREATITIS 10 0.0002
864 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
865 DYSPHONIA 11 0.0002
866 EAR INFECTION 5 0.0002
867 MOVEMENT DISORDER 6 0.0002
868 LIVER FUNCTION TEST INCREASED 4 0.0002
869 DISEASE PROGRESSION 22 0.0002
870 RHINORRHOEA 12 0.0002
871 LACTIC ACIDOSIS 6 0.0002
872 FREQUENT BOWEL MOVEMENTS 5 0.0002
873 OFF LABEL USE 162 0.0002
874 MENTAL DISORDER 8 0.0002
875 ILL-DEFINED DISORDER 11 0.0002
876 CONDITION AGGRAVATED 55 0.0002
877 ANGIOEDEMA 8 0.0002
878 VISUAL ACUITY REDUCED 6 0.0002
879 STEVENS-JOHNSON SYNDROME 4 0.0002
880 HEPATOTOXICITY 4 0.0002
881 FEELING COLD 5 0.0002
882 GAIT INABILITY 6 0.0002
883 SNEEZING 4 0.0002
884 THROAT IRRITATION 8 0.0002
885 TYPE 2 DIABETES MELLITUS 6 0.0002
886 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
887 CANDIDA INFECTION 3 0.0002
888 EYE PAIN 10 0.0002
889 PRODUCT AVAILABILITY ISSUE 4 0.0002
890 PRODUCT USE ISSUE 33 0.0002
891 INFLAMMATION 9 0.0002
892 OROPHARYNGEAL PAIN 16 0.0002
893 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
894 COGNITIVE DISORDER 8 0.0002
895 FEELING ABNORMAL 41 0.0002
896 DEPRESSED MOOD 9 0.0002
897 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
898 PSYCHOTIC DISORDER 5 0.0002
899 COMA 8 0.0002
900 LACRIMATION INCREASED 5 0.0002
901 SEIZURE 19 0.0002
902 ACCIDENTAL OVERDOSE 6 0.0002
903 PRODUCT DOSE OMISSION ISSUE 48 0.0002
904 EXTRAPYRAMIDAL DISORDER 4 0.0002
905 AGEUSIA 4 0.0002
906 THERAPY CESSATION 8 0.0002
907 ANAPHYLACTIC SHOCK 4 0.0002
908 APPLICATION SITE ERYTHEMA 4 0.0002
909 OSTEONECROSIS 5 0.0002
910 EYE DISORDER 5 0.0002
911 BLOOD PRESSURE ABNORMAL 3 0.0002
912 INFUSION RELATED REACTION 10 0.0002
913 ASTHMA 17 0.0002
914 NEOPLASM MALIGNANT 10 0.0001
915 ABORTION SPONTANEOUS 6 0.0001
916 JAUNDICE 4 0.0001
917 DRUG EFFECT DECREASED 8 0.0001
918 THROAT TIGHTNESS 4 0.0001
919 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
920 HEPATIC ENZYME INCREASED 10 0.0001
921 MOOD ALTERED 4 0.0001
922 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
923 EXPOSURE DURING PREGNANCY 9 0.0001
924 ADVERSE DRUG REACTION 13 0.0001
925 NIGHTMARE 5 0.0001
926 ARTHROPATHY 8 0.0001
927 URTICARIA 24 0.0001
928 CRYING 5 0.0001
929 PANIC ATTACK 5 0.0001
930 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
931 INTENTIONAL PRODUCT MISUSE 12 0.0001
932 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
933 DRUG INEFFECTIVE 178 0.0001
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
935 IRRITABILITY 8 0.0001
936 TREATMENT FAILURE 11 0.0001
937 DISCOMFORT 8 0.0001
938 NERVOUS SYSTEM DISORDER 4 0.0001
939 ABNORMAL BEHAVIOUR 5 0.0001
940 MOOD SWINGS 4 0.0001
941 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
942 RHEUMATOID ARTHRITIS 14 0.0001
943 PSORIATIC ARTHROPATHY 5 0.0001
944 DEVICE ISSUE 11 0.0001
945 PRODUCT SUBSTITUTION ISSUE 7 0.0001
946 ADVERSE EVENT 11 0.0001
947 EYE PRURITUS 4 0.0001
948 OVERDOSE 25 0.0001
949 VAGINAL HAEMORRHAGE 5 0.0001
950 DEVICE MALFUNCTION 8 0.0001
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
952 COLITIS ULCERATIVE 5 0.0001
953 THERAPY NON-RESPONDER 5 0.0001
954 NO ADVERSE EVENT 20 0.0001
955 DRUG EFFECT INCOMPLETE 4 0.0001
956 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
957 UNDERDOSE 8 0.0001
958 TINNITUS 5 0.0001
959 DISEASE RECURRENCE 5 0.0001
960 RASH ERYTHEMATOUS 5 0.0001
961 INJECTION SITE PRURITUS 7 0.0001
962 PSORIASIS 13 0.0001
963 DEVICE BREAKAGE 4 0.0001
964 SUICIDAL IDEATION 9 0.0001
965 LUNG NEOPLASM MALIGNANT 4 0.0001
966 NERVOUSNESS 5 0.0001
967 HYPOACUSIS 4 0.0001
968 DISTURBANCE IN ATTENTION 5 0.0001
969 DRUG WITHDRAWAL SYNDROME 8 0.0001
970 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
971 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
972 SKIN IRRITATION 4 0.0001
973 INJECTION SITE REACTION 6 0.0001
974 BREAST CANCER 8 0.0001
975 INJECTION SITE PAIN 26 0.0001
976 MULTIPLE SCLEROSIS 4 0.0001
977 INTERSTITIAL LUNG DISEASE 4 0.0001
978 SUICIDE ATTEMPT 5 0.0001
979 INJECTION SITE ERYTHEMA 10 0.0001
980 AGGRESSION 4 0.0001
981 ACNE 6 0.0001
982 INCORRECT DOSE ADMINISTERED 18 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
984 INTENTIONAL OVERDOSE 5 0.0001
985 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
986 EYE IRRITATION 4 0.0001
987 INJECTION SITE SWELLING 5 0.0001
988 PROSTATE CANCER 5 0.0001
989 INJECTION SITE BRUISING 4 0.0001
990 INJECTION SITE HAEMORRHAGE 4 0.0001
991 DRUG ABUSE 4 0.0000
992 PRODUCT QUALITY ISSUE 6 0.0000